On this page of StockholderLetter.com we present the latest annual shareholder letter from Neuraxis, INC — ticker symbol NRXS. Reading current and past NRXS letters to shareholders can bring important insights into the investment thesis.
NEURAXIS, INC. 2023 ANNUAL REPORT
Neuraxis, Inc. Board of Directors and Executive Officers as of June 28, 2024
BOARD OF DIRECTORS
Name
Principal Occupation or Employment
Brian Carrico
President, Chief Executive Officer, and Director, of
Neuraxis, Inc.
Co-founder of Neuraxis, Inc.
National Sales Manager of Terumo Interventional Systems
President, BCBS of Indiana at Anthem, Inc.
President and Chief Financial Officer of Capri Communities and Bridges Home
Healthcare
Dr. Christopher Robin Brown
Bradley Mitch Watkins
Beth Keyser
Kristin Ferge
EXECUTIVE OFFICERS
Name
Principal Occupation or Employment
Brian Carrico
Timothy Henrichs
Dr. Adrian Miranda
Dr. Thomas Carrico
Chief Executive Officer
Chief Financial Officer
Chief Medical Officer, Senior Vice President of Science and Technology
Chief Regulatory Officer, Compliance Officer and Privacy Officer
This Annual Report contains forward-looking statements. All statements contained in this Annual Report other than
statements of historical fact, including statements regarding our future results of operations and financial position, our
business strategy and plans, and our objectives for future operations, are forward-looking statements. Please read the section
of our Annual Report on Form 10-K entitled    Forward-Looking Statements    for a discussion of the limitations and risks
regarding forward-looking statements made in this Annual Report. These forward-looking statements are subject to a number
of risks, uncertainties and assumptions, including those described in Part I, Item 1A,    Risk Factors    of our Annual Report on
Form 10-K included herein, which may cause actual results to differ materially from those contained in any forward-looking
statements we may make. We undertake no obligation to revise or publicly release the results of any revision to these
forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned not to place
undue reliance on such forward-looking statements.
 • shareholder letter icon 7/1/2024 Letter Continued (Full PDF)
 • Benford's Law Stocks icon NRXS Benford's Law Stock Score = 84


NRXS Shareholder/Stockholder Letter Transcript:

NEURAXIS, INC. 2023 ANNUAL REPORT
Neuraxis, Inc. Board of Directors and Executive Officers as of June 28, 2024
BOARD OF DIRECTORS
Name
Principal Occupation or Employment
Brian Carrico
President, Chief Executive Officer, and Director, of
Neuraxis, Inc.
Co-founder of Neuraxis, Inc.
National Sales Manager of Terumo Interventional Systems
President, BCBS of Indiana at Anthem, Inc.
President and Chief Financial Officer of Capri Communities and Bridges Home
Healthcare
Dr. Christopher Robin Brown
Bradley Mitch Watkins
Beth Keyser
Kristin Ferge
EXECUTIVE OFFICERS
Name
Principal Occupation or Employment
Brian Carrico
Timothy Henrichs
Dr. Adrian Miranda
Dr. Thomas Carrico
Chief Executive Officer
Chief Financial Officer
Chief Medical Officer, Senior Vice President of Science and Technology
Chief Regulatory Officer, Compliance Officer and Privacy Officer
This Annual Report contains forward-looking statements. All statements contained in this Annual Report other than
statements of historical fact, including statements regarding our future results of operations and financial position, our
business strategy and plans, and our objectives for future operations, are forward-looking statements. Please read the section
of our Annual Report on Form 10-K entitled    Forward-Looking Statements    for a discussion of the limitations and risks
regarding forward-looking statements made in this Annual Report. These forward-looking statements are subject to a number
of risks, uncertainties and assumptions, including those described in Part I, Item 1A,    Risk Factors    of our Annual Report on
Form 10-K included herein, which may cause actual results to differ materially from those contained in any forward-looking
statements we may make. We undertake no obligation to revise or publicly release the results of any revision to these
forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned not to place
undue reliance on such forward-looking statements.



shareholder letter icon 7/1/2024 Letter Continued (Full PDF)
 

NRXS Stockholder/Shareholder Letter (Neuraxis, INC) | www.StockholderLetter.com
Copyright © 2023 - 2024, All Rights Reserved

Nothing in StockholderLetter.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.